Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Moderna’s virus vaccine shows overwhelming success in U.S. tests By Staff Reports 2 weeks ago Moderna said Monday its COVID-19 vaccine is proving highly effective in a major trial, a
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Neuropilin-1 drives SARS-CoV-2 infectivity, finds breakthrough study By Staff Reports 1 month ago In a major breakthrough an international team of scientists, led by the University of Bristol,
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Dried blood spot sampling offers an inexpensive way to widen access to antibody testing for COVID-19 By Staff Reports 2 months ago Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting
Biotechnology Clinical Trials Coronavirus rare diseases Vaccines Investigational COVID-19 vaccine well-tolerated, generates immune response in older adults By Staff Reports 2 months ago A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown
rare diseases Positive Results Reported in Study for the Treatment of Niemann-Pick disease Type C By Staff Reports 2 months ago A multinational clinical trial investigating a new treatment of Niemann-Pick disease Type C (NPC), reported
Biotechnology Cardiology Clinical Trials Coronavirus Coronavirus COVID-19 drug development Infectious Diseases rare diseases Potential new drug to mitigate SARS-CoV-2 infection consequences By Staff Reports 3 months ago Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting By Staff Reports 3 months ago Eli Lilly and Company said proof of concept data from an interim analysis of the
Biotechnology Centers for Disease Control Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Antibody responses in COVID-19 patients could guide vaccine design By Staff Reports 3 months ago A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Vaccines Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses By Staff Reports 3 months ago Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show
Coronavirus Coronavirus COVID-19 rare diseases COVID-19 Fatality Risk Is Double Earlier Estimates By Staff Reports 5 months ago In one of the most robust studies of COVID-19 mortality risk in the United States,
Coronavirus Kidney disease kidney function decline rare diseases COVID-19 Can Cause Kidney Injury, Yet Most Americans Don’t Know It By Staff Reports 6 months ago According to a recent Harris Poll, too many people don’t know all they should about
Biotechnology Clinical Trials Coronavirus rare diseases How the coronavirus could be prevented from invading a host cell By Staff Reports 6 months ago How might the novel coronavirus be prevented from entering a host cell in an effort
Biotechnology Epidemiology Immunotherapies Infection Control Infectious Diseases rare diseases New antigen test for detecting COVID-19 could help triage patients during the pandemic By Staff Reports 7 months ago COVID-19 Ag Respi-Strip test can identify an infected person in 15 minutes at point-of-care sites
Biotechnology Clinical Trials Coronavirus drug development rare diseases Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research By Staff Reports 7 months ago An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as
Biotech Company News Biotechnology Coronavirus rare diseases Q BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics By Staff Reports 8 months ago Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, today announced that together with
Clinical Trials Coronavirus rare diseases New Rutgers Saliva Test for Coronavirus Gets FDA Approval By Staff Reports 8 months ago The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR
Coronavirus COVID-19 Pharmaceuticals rare diseases Repurposing Existing Drugs Could Offer Faster Path to COVID-19 Treatment By Staff Reports 8 months ago As hospitals around the world become increasingly overwhelmed by severe cases of COVID-19, researchers are
Clinical Trials Coronavirus rare diseases Penn Launches Clinical Trial to Evaluate Hydroxychloroquine to Treat, Prevent COVID-19 By Staff Reports 8 months ago A new trial led by the Perelman School of Medicine at the University of Pennsylvania
Biotechnology Coronavirus Pharmaceuticals Prodrug rare diseases FDA clears emergency use of malaria drug, Chloroquine to treat COVID-19 By Staff Reports 8 months ago The Food and Drug Administration has authorized the emergency use of two malaria drugs seen
Biotechnology Clinical Trials Coronavirus drug development Pharmaceuticals rare diseases FDA-approved drugs could help fight COVID-19 By Staff Reports 9 months ago Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold